Similar Papers

Paper Title
Journal
Date
Author
Impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany
Frank Griesinger ...
Lung Cancer | VOL. 172
Frank Griesinger, et. al.Frank Griesinger ...
06 Aug 2022
Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer.
Ruoding Tan ... Peter Lambert
The oncologist | VOL. 27
Ruoding Tan, et. al.Ruoding Tan ... Peter Lambert
19 Feb 2022
Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer
Zsofia Dora Drobni ... Tomas G Neilan
Journal for ImmunoTherapy of Cancer | VOL. 11
Zsofia Dora Drobni, et. al.Zsofia Dora Drobni ... Tomas G Neilan
01 Jul 2023
Impact of immune checkpoint inhibitors on survival outcomes in advanced gastric cancer in Japan: A real-world analysis.
Toru Kadono ... Ken Kato
Cancer medicine | VOL. 13
Toru Kadono, et. al.Toru Kadono ... Ken Kato
01 Jun 2024
View more papers

More From: JTO Clinical and Research Reports

Paper Title
Journal
Date
Author
Temporal trends in the utilization and survival outcomes of lobar, segmental, and wedge resection for early-stage NSCLC, 2004-2020
Eden Z Deng ... Nasser Altorki
JTO Clinical and Research Reports | VOL. -
Eden Z Deng, et. al.Eden Z Deng ... Nasser Altorki
01 Jan 2025
Impact of immune checkpoint inhibitors and local radical treatment on survival outcomes in synchronous oligometastatic NSCLC
Mandy Jongbloed ... Lizza E.L Hendriks
JTO Clinical and Research Reports | VOL. -
Mandy Jongbloed, et. al.Mandy Jongbloed ... Lizza E.L Hendriks
01 Jan 2025
Tocilizumab for Steroid Pulse-Refractory Cytokine Release Syndrome in Chemotherapy With Durvalumab Plus Tremelimumab for Non-Small Cell Lung Cancer: A Case Report
Ken Yamamoto ... Akito Hata
JTO Clinical and Research Reports | VOL. -
Ken Yamamoto, et. al.Ken Yamamoto ... Akito Hata
01 Jan 2025
Mucocutaneous Adverse Events in Cancer Patients Treated with Selective RET Kinase Inhibition
Rachel E Reingold ... Alexander Drilon
JTO Clinical and Research Reports | VOL. -
Rachel E Reingold, et. al.Rachel E Reingold ... Alexander Drilon
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.